PAVmed Inc. (NASDAQ: PAVM) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $790 thousand versus the consensus estimate of $658 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.